关注
David Hellerstein
David Hellerstein
New York State Psychiatric Institute
在 nyspi.columbia.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Effectiveness of St John's wort in major depression: a randomized controlled trial
RC Shelton, MB Keller, A Gelenberg, DL Dunner, R Hirschfeld, ME Thase, ...
Jama 285 (15), 1978-1986, 2001
6602001
Single-dose psilocybin for a treatment-resistant episode of major depression
GM Goodwin, ST Aaronson, O Alvarez, PC Arden, A Baker, JC Bennett, ...
New England Journal of Medicine 387 (18), 1637-1648, 2022
4962022
Antidepressants normalize the default mode network in patients with dysthymia
J Posner, DJ Hellerstein, I Gat, A Mechling, K Klahr, Z Wang, PJ McGrath, ...
JAMA psychiatry 70 (4), 373-382, 2013
2802013
A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
DJ Hellerstein, P Yanowitch, J Rosenthal, LW Samstag, M Maurer, ...
The American journal of psychiatry 150 (8), 1169-1175, 1993
1851993
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes
JH Kocsis, S Zisook, J Davidson, R Shelton, K Yonkers, DJ Hellerstein, ...
American Journal of Psychiatry 154 (3), 390-395, 1997
1801997
A randomized prospective study comparing supportive and dynamic therapies: Outcome and alliance
DJ Hellerstein, RN Rosenthal, H Pinsker, LW Samstag, JC Muran, ...
The Journal of psychotherapy practice and research 7 (4), 261, 1998
1691998
The clinical significance of command hallucinations.
D Hellerstein, W Frosch, HW Koenigsberg
The American journal of psychiatry 144 (2), 219-221, 1987
1681987
A prospective study of integrated outpatient treatment for substance-abusing schizophrenic patients
DJ Hellerstein, RN Rosenthal, CR Miner
American Journal on Addictions 4 (1), 33-42, 1995
1641995
Outpatient group therapy for schizophrenic substance abusers.
DJ Hellerstein, B Meehan
The American journal of psychiatry, 1987
1551987
Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders
CR Miner, RN Rosenthal, DJ Hellerstein, LR Muenz
Archives of General Psychiatry 54 (8), 706-712, 1997
1301997
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality
DJ Hellerstein, JH Kocsis, D Chapman, JW Stewart, W Harrison
American Journal of Psychiatry 157 (9), 1436-1444, 2000
1112000
Decreasing the use of restraint and seclusion among psychiatric inpatients
DJ Hellerstein, AB Staub, E Lequesne
Journal of Psychiatric Practice® 13 (5), 308-317, 2007
942007
Adding group psychotherapy to medication treatment in dysthymia: a randomized prospective pilot study
DJ Hellerstein, SAS Little, LW Samstag, S Batchelder, JC Muran, M Fedak, ...
The Journal of psychotherapy practice and research 10 (2), 93, 2001
912001
Interpersonal change in brief supportive psychotherapy
RN Rosenthal, JC Muran, H Pinsker, D Hellerstein, A Winston
The Journal of psychotherapy practice and research 8 (1), 55, 1999
761999
Neurocognitive predictors of antidepressant clinical response
GE Bruder, JE Alvarenga, D Alschuler, K Abraham, JG Keilp, ...
Journal of affective disorders 166, 108-114, 2014
742014
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life
GM Goodwin, ST Aaronson, O Alvarez, M Atli, JC Bennett, M Croal, ...
Journal of Affective Disorders 327, 120-127, 2023
732023
A model of integrated service for outpatient treatment of patients with comorbid schizophrenia and addictive disorders
RN Rosenthal, DJ Hellerstein, CR Miner
American Journal on Addictions 1 (4), 339-348, 1992
691992
Pattern recognition of magnetic resonance imaging-based gray matter volume measurements classifies bipolar disorder and major depressive disorder
H Rubin-Falcone, F Zanderigo, B Thapa-Chhetry, M Lan, JM Miller, ...
Journal of affective disorders 227, 498-505, 2018
682018
Supportive therapy as the treatment model of choice
DJ Hellerstein, H Pinsker, RN Rosenthal, S Klee
The Journal of Psychotherapy Practice and Research 3 (4), 300, 1994
661994
Assessing the risk–benefit profile of classical psychedelics: A clinical review of second-wave psychedelic research
D Bender, DJ Hellerstein
Psychopharmacology, 1-26, 2022
652022
系统目前无法执行此操作,请稍后再试。
文章 1–20